Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06473584 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Study of the Prevalence of Diabetes and Pre-diabetes in Réunion Island

Study acronym: PREVADIABRUN
StatusRecruiting
PhaseNot applicable
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 9 months later Mar 2026 → Dec 31, 2026
See other at-risk trials from Centre Hospitalier Universitaire de la Réunion

Record History

  1. Notable Primary completion pushed from Mar 2026 to Dec 31, 2026
    • Study completion date: Dec 2026 to Dec 31, 2026
    v5
  2. Minor Re-verified, no change to tracked fieldsv4
  3. Notable Trial status: Not Yet Recruiting to Recruiting
    • Study sites: 0 to 1
    • Primary completion date: Sep 2026 to Mar 2026
    • Start date changed from estimate of Apr 2025 to Apr 2, 2025
    v3
  4. Notable Primary completion date: Sep 2025 to Sep 2026
    • Start date: Sep 2024 to Apr 2025
    • Study completion date: Dec 2025 to Dec 2026
    v2
  5. Minor Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
In view of the new priority given to diabetes in Réunion and the implementation of an ambitious plan to combat the disease at regional level, which includes the identification and management of pre-diabetes, the need for up-to-date data on the extent of these 2 diseases (diabetes and pre-diabetes) has become essential. These two diseases have known risk factors: age, overweight, obesity, high waist circumference, family history, hypertension, eating habits and physical activity, all of which form part of a risk score for developing diabetes: the Findrisk recommended by the Haute Autorité de Santé for identifying people at risk of diabetes. Given the specific population characteristics of Réunion compared with Finland, where this score has been validated, it would seem important to be able to measure these risk indicators in the population as a function of carbohydrate status in order to check that the proposed thresholds are appropriate for the population of Réunion. Finally, cardiovascular risk has been described as early as the pre-diabetes stage. Given the young age of onset of diabetes in Réunion and the high proportion of diagnoses of diabetes made following the occurrence of a cardiovascular complication, the study of the prognosis of carbohydrate status on the occurrence of complications using the social security information system will be offered on a voluntary basis to study subjects (via a probabilistic social security link).
Trial Details
NCT Number NCT06473584
Lead Sponsor Centre Hospitalier Universitaire de la Réunion
Collaborators: Agence Régionale de Santé de La Réunion
Conditions
(from sponsor)
Diabetes
Related terms Diabetes Mellitus
Enrollment 2,000 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov